Bioscan Research
Ahmedabad, India
◆ About Bioscan Research
Bioscan Research develops non-invasive, point-of-care medical devices for early detection of brain injuries and intracranial hemorrhage. Its core product, CEREBO, uses optics, electronics, and machine learning to help clinicians and first responders rapidly screen patients in emergency and trauma settings.[3][4][10][12]
◆ What sets it apart
It offers a portable, non-invasive brain-bleed screening device intended to deliver hospital-grade neurological assessment at the point of care within minutes.[1][7][10][12]
◆ Sectors
◆ Business
Modelhardware
CustomerHospitals, trauma centers, emergency departments, first responders, and other point-of-care clinical users
◆ Notable
- Clinically validated the device on 42 patients with 100% accuracy to detect haemorrhages
- Raised a $1 million seed round led by Unicorn India Ventures
- Holds multiple patent cases for its technology
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Bioscan Research do?
Bioscan Research develops non-invasive, point-of-care medical devices for early detection of brain injuries and intracranial hemorrhage. Its core product, CEREBO, uses optics, electronics, and machine learning to help clinicians and first responders rapidly screen patients in emergency and trauma settings.[3][4][10][12]
Where is Bioscan Research based?
Bioscan Research is based in Ahmedabad, India, founded in 2017.
How much has Bioscan Research raised?
Bioscan Research has raised $1M in tracked funding and is currently at the seed stage.
Who has invested in Bioscan Research?
Investors in Bioscan Research include Unicorn India Ventures, BIRAC, Capria Ventures, icreate (Incubator), Startup Incubation and Innovation Centre, Zone Startups India, Indian Institute of Technology Kanpur and MedTech Innovator Asia Pacific.